Lee H, Yang H-M, Lee H-Y, Kim J-J, Choi D-J, Seung K-B, Jeon E-S, Ha J-W, Rim S-J, Park JB, Shin J-H, Oh B-H. Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies. Clin Ther. 2012;34(6):1273-1289.

Chi YH, Lee H, Paik SH et al. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fimasartan, a Novel Angiotensin II Receptor Antagonist, Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects. Am J Cardiovasc Drugs. 2011 Oct 1. 1(5):335-46.

Xie HG, Cao YJ, Gauda EB, Agthe AG, Hendrix CW, Lee H. Clonidine Clearance Matures Rapidly during the Early Postnatal Period: A Population Pharmacokinetic Analysis in Newborns with Neonatal Abstinence Syndrome. J Clin Pharmacol. 2011:51:502-511.

Park CG, Lee H, Choi JW, Lee SJ, Kim SH, Lim HE. Non-concurrent Dosing Attenuated Pharmacokinetic Drug Interaction between Amlodipine and Simvastatin. Int J Clin Pharmacol Ther. 2010; 48(8):497-503.

Xu Z, Lee H, Vu T, Hu C, Yan H, Baker D, Hsu B, Pendley C, Wagner C, Davis HM, Zhou H. Population Pharmacokinetics of Golimumab in Patients with Ankylosing Spondylitis: Impact of Body Weight and Immunogenicity. Int J Clin Pharmacol Ther. 2010;48(9):596-607.

Xu Z, Vu T, Lee H, Hu C, Ling J, Yan H, Baker D, Beutler A, Pendley C, Wagner C, Davis HM, Zhou H. Population Pharmacokinetics of Golimumab, an Anti-Tumor Necrosis Factor-Alpha Human Monoclonal Antibody, in Patients with Psoriatic Arthritis. J Clin Pharmacol, 2009;49:1056-1070.

Lee H. Chapter 12. Utilizing the Preclinical Database to Support Clinical Drug Development. In: Preclinical Drug Development, edited by Mark Rogge and David R. Taft, Taylor & Francis, Boca Raton, London, New York, Singapore. 2005 & 2009 (2nd ed.) (ISBN: 978-1420084726)

Lee H. Chapter 13. Regulation for Drug Development and Competition. In: Introduction to Pharmaceutical Medicine, Novo Consulting, Seoul, 2009

Lee HA, Leavens TL, Mason SE, Monteiro-Riviere NA, Riviere JE. Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model. Nano Letters. 2009 Feb;9(2):794-9. doi: 10.1021/nl803481q.

Rea RS, Capitano B, Bies R, Bigos KL, Smith R, Lee H. Suboptimal Aminoglycoside Dosing in Critically Ill Patients, Ther Drug Monit, 2008;30:674–681.

O’brien S, Lee H, Ritchey, AK. Once-Daily Enoxaparin in Pediatric Thromboembolism: A Dose Finding and Pharmacodynamics Study, Journal of Thrombosis and Haemostasis, 2007 Sep;5(9):1985-7.

Lee H. Let Us Not Forget Woo-Suk Hwang. The Young Physicians Press. Seoul, Korea, 2007 (ISBN: 8991232124).